Catalog Advanced Search

Search by Category
Search by Format
Search by Type
Sort By
Search by Keyword
Search by Category
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By

121 Results

  • Product Image: The Role of Senescent Cells in Skeletal Aging and Repair

    The Role of Senescent Cells in Skeletal Aging and Repair
    Contains 1 Component(s) Includes a Live Web Event on 09/29/2026 at 2:00 PM (EDT)

    Join Dr. Sundeep Khosla as they discuss "The role of senescent cells in skeletal aging and repair " moderated by Dr. Matthew Prideaux

    Join Dr. Sundeep Khosla as they discuss "The Role of Senescent Cells in Skeletal Aging and Repair " moderated by Dr. Matthew Prideaux

    Learning Objectives:
    1. Understand mechanisms driving cellular senescence in bone and other tissues
    2. Define consequences of global and cell-specific senescent cell clearance on the skeleton
    3. Define differences in mesenchymal versus immune cell senescent phenotypes
    4. Describe progress and challenges to clinical translation of senolytic

    This webinar is hosted by the ASBMR Muscle and Bone Disease Scientific Interest Group (SIG). The Scientific Interest Groups, brought to you by the Membership Engagement Committee (MEC), aim to empower members through fostering meaningful engagement and collaboration within specific research areas. SIGs are dedicated to promoting year-round connectivity, enhancing networking opportunities, and facilitating mentorship that advances careers. By ensuring inclusivity for all members, SIGs strive to provide exclusive benefits that extend beyond our Annual Meeting, creating a vibrant and supportive community for all.

    Dr. Sundeep Khosla

    Dr. Sundeep Khosla

    MD

    Dr. Sundeep Khosla is the Dr. Francis Chucker and Nathan Landow Research Professor of Medicine and Physiology and a Mayo Foundation Distinguished Investigator. Dr. Khosla received his A.B. degree from Harvard College and his M.D. from Harvard Medical School. He was subsequently a resident in Internal Medicine and a fellow in Endocrinology at the Massachusetts General Hospital. In 1988 he moved to Mayo Clinic, where his research has focused on mechanisms of age-related bone loss and osteoporosis. Dr. Khosla has served as Director of the Center for Clinical and Translational Science and Dean for Clinical and Translational Science at Mayo Clinic. He has also served as Chair of the NIH SBDD Study Section, on the Councils of the National Institute on Aging and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and as President of the American Society for Bone and Mineral Research (ASBMR). Dr. Khosla has received numerous awards and honors for his work, including the Frederic C. Bartter Award for Clinical Investigation and the William F. Neuman Award for Outstanding Scientific Contributions from the ASBMR, the presentation of the Louis V. Avioli Plenary Lecture at the ASBMR annual meeting, the Outstanding Clinical Investigator Award and Plenary Lecture from the Endocrine Society, the Frontiers in Science Award from the American Association of Clinical Endocrinologists, the Jacobaeus Prize for outstanding research in Endocrinology, and election to the ASCI and AAP.  Dr. Khosla has served as the Editor-in-Chief of Bone, as Associate Editor of the Journal of Bone and Mineral Research and as a member of the editorial boards for the Journal of Clinical Investigation, Journal of Bone and Mineral Research, Journal of Clinical Endocrinology and Metabolism, Bone, and Endocrine Reviews.

    Dr. Matthew Prideaux

    Dr. Matthew Prideaux (Moderator)

    Ph.D

  • Product Image: ASBMR Annual Meeting First-Time Attendee Pre-Meeting Webinar

    ASBMR Annual Meeting First-Time Attendee Pre-Meeting Webinar
    Contains 1 Component(s) Includes a Live Web Event on 09/14/2026 at 2:30 PM (EDT)

    During this session, we share valuable tips on preparing for your trip to Boston, strategies to avoid meeting burnout, and how to maximize your networking opportunities.

    During this session, we share valuable tips on preparing for your trip to Boston, strategies to avoid meeting burnout, and how to maximize your networking opportunities.

  • Product Image: Getting Started with Performing Single Cell RNASeq Analyses on Musculoskeletal Cells

    Getting Started with Performing Single Cell RNASeq Analyses on Musculoskeletal Cells
    Contains 1 Component(s) Includes a Live Web Event on 08/26/2026 at 10:00 AM (EDT)

    Join Drs. Matthew Greenblatt and Dr. Federico La Manna in their 2-part webinar. Dr. Greenblatt will present on, "Getting Started with Performing Single Cell RNASeq Analyses on Musculoskeletal Cells" and Dr. La Manna will lead an interactive session where he will guide attendees step-by-step on how to do basic programming to generate a map of cell clusters and identify some top genes expressed by each cluster using a small data set.

    Agenda

    Dr. Matthew Greenblatt’s Presentation: 10AM – 11:15AM ET
    Dr. Federico La Manna’s Workshop: 11:15AM – 12:30 PM ET

    Learning Objectives:

    1. Understand the key experimental parameters impacting the analysis of single cell RNA sequencing data, and the strengths and weaknesses of this technique.
    2. Be able to analyze single cell RNA sequencing data using the Seurat platform.
    3. Understand key decision points in the analytic pipeline for single cell RNA sequencing data and how this impacts the results of the analysis.
  • Product Image: Elucidating muscle–bone crosstalk: the power of lipidomics and metabolomics

    Elucidating muscle–bone crosstalk: the power of lipidomics and metabolomics
    Contains 1 Component(s)

    Join Dr. Marco Brotto as they discuss "Elucidating muscle–bone crosstalk: the power of lipidomics and metabolomics" moderated by Dr. Kamal Awad.

    Join Dr. Marco Brotto as they discuss "Elucidating muscle–bone crosstalk: the power of lipidomics and metabolomics" moderated by Dr. Kamal Awad.

    Learning Objectives:
    1. Describe the biological basis of muscle–bone crosstalk in aging and musculoskeletal disease.

    2. Explain how lipidomics and metabolomics can reveal pathways and biomarkers relevant to osteosarcopenia.

    3. Discuss the translational potential of these approaches for identifying clinically useful biomarkers and therapeutic targets in musculoskeletal disorders.

    This webinar is hosted by the ASBMR Muscle and Bone Scientific Interest Group (SIG). The Scientific Interest Groups, brought to you by the Membership Engagement Committee (MEC), aim to empower members through fostering meaningful engagement and collaboration within specific research areas. SIGs are dedicated to promoting year-round connectivity, enhancing networking opportunities, and facilitating mentorship that advances careers. By ensuring inclusivity for all members, SIGs strive to provide exclusive benefits that extend beyond our Annual Meeting, creating a vibrant and supportive community for all.

    Dr. Marco Brotto

    Dr. Marco Brotto

    BSN, MPharm, PhD

    Bone-Muscle Research Center, Institute of Biomanufacturing and Precision Medicine for North Texas (IMPRINT), College of Nursing and Innovation, University of Texas at Arlington

    Dr. Marco Brotto is the George W. & Hazel M. Jay Endowed Professor and Director of the Bone-Muscle Research Center at the University of Texas at Arlington. He is a clinician-scientist with expertise in muscle physiology, cell biology, and translational research models. His work spans experimental platforms ranging from intact muscle and single-muscle fibers to FDA-aligned analytical chemistry approaches. In this webinar, Dr. Brotto will discuss key concepts in muscle–bone crosstalk and highlight how lipidomics and metabolomics can be used to identify blood, serum, fat, muscle, and tissue biomarkers of age-related decline in musculoskeletal function, including osteosarcopenia, as well as other musculoskeletal disorders.

     

    Dr. Kamal Awad

    Dr. Kamal Awad (Moderator)

    Assistant Professor of Research

    The Bone-Muscle Research Center, College of Nursing and Health Innovations, at the University of Texas at Arlington

  • ASBMR 2025 Annual Meeting Recordings
    Contains 65 Component(s) Recorded On: 09/05/2025

    Recordings from the ASBMR 2025 Annual Meeting Recordings

    Recordings from the ASBMR 2025 Annual Meeting Recordings

  • Product Image: Clinical and Molecular Aspects of Osteopetrosis and SOST-Related Sclerosing Bone Dysplasias

    Clinical and Molecular Aspects of Osteopetrosis and SOST-Related Sclerosing Bone Dysplasias
    Contains 1 Component(s)

    Join Prof. Uwe Kornak and Dr. Natasha Appelman-Dijkstra as they discuss " Clinical and Molecular Aspects of Osteopetrosis and SOST-Related Sclerosing Bone Dysplasias" moderated by Dr. Michael Collins.

    Join Prof. Uwe Kornak and Dr. Natasha Appelman-Dijkstra as they discuss " Clinical and Molecular Aspects of Osteopetrosis and SOST-Related Sclerosing Bone Dysplasias" moderated by Dr. Michael Collins.

    Learning objectives:

    1. Classification and differential diagnosis of sclerosing skeletal dysplasias
    2. Pathophysiological mechanisms underlying osteopetrosis and SOST-related disorders and clinical consequences
    3. Clinical burden, patient management strategies, and emerging therapeutic approaches for osteopetrosis and SOST-related disorders

     

    Dr. Natasha Appelman-Dijkstra

    Dr. Natasha Appelman-Dijkstra

    Dr. Natasha Appelman-Dijkstra is a  Internist-endocrinologist and full professor Internal Medicine in particular Bone and Mineral Disorders at Leiden University. Coordinator of the European Registries of Rare Endocrine and Bone disorders. 

    Prof. Uwe Kornak

    Prof. Uwe Kornak

    Institute of Human Genetics University Medical Center Göttingen, Germany

    After studying biochemistry and medicine in Berlin and Hamburg Uwe Kornak did his PhD at the Center for Molecular Neurobiology Hamburg, where he started working on osteopetrosis. After that, he did a postdoc in Paris before joining the Max Planck Institute for Molecular Genetics and the Institute for Medical Genetics at Charité-Universitätsmedizin Berlin in 2003. After establishing a research group at the BIH Centre for Regenerative Therapies (BCRT) and the Charité he finished his clinical specialization in human genetics and became Professor for Mechanisms of Genetics Diseases in 2011. He was deputy director of the institute of Medical Genetics and Human Genetics at Charité and of the genetic diagnostics department at Labor Berlin GmbH. In 2020 he moved to the University Medical Center Göttingen to become head of the Department for Medical Genetics at the Institute of Human Genetics, where he established an interdisciplinary Center for Rare Skeletal Disorders. Uwe Kornak participated in many national and international research consortia on rare skeletal and metabolic disorders. After he had participated in the identification of numerous genes for skeletal disorders he is now focussing on diagnostics, disease mechanisms and therapeutic strategies.

    Dr. Michael Collins

    Dr. Michael Collins (Moderator)

  • Product Image: ESI Clinical Case Workshop on Weight Loss Therapies and Their Potential Effects

    ESI Clinical Case Workshop on Weight Loss Therapies and Their Potential Effects
    Contains 1 Component(s)

    Emerging weight loss therapies and potential effects on body composition and fracture risk Speakers: David Scott PhD, BHM, FASBMR., and Jakub Mesinovic, PhD. Wednesday 05/20/2026 at 8:30 AM EST

    Learning Objectives: 

    1. Recognize the impact of pharmacologically induced weight loss on body composition, with a focus on the potential risks of significant lean mass losses in vulnerable populations. 

    2. Develop understanding of current evidence regarding the skeletal consequences of intensive weight management on bone mineral density, bone microarchitecture, and fracture risk. 

    3. Apply practical, evidence-informed strategies to preserve muscle and bone during weight loss therapy, alongside approaches to identifying individuals who require closer musculoskeletal surveillance.

    Speakers: David Scott PhD, BHM, FASBMR., and Jakub Mesinovic, PhD

    Wednesday 05/20/2026 at 8:30 AM EST

    David Scott PhD, BHM, FASBMR

    David Scott PhD, BHM, FASBMR

    Professor

    Deakin University

    Dr. David Scott is a professor at the Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences at Deakin University. His research is aimed at reducing the disease burden of sarcopenia, osteoporosis and obesity in older adults.

    He has led several clinical trials exploring the effects of exercise and nutrition interventions, including weight loss, on improving body composition, physical function and bone health in older populations. He has a keen interest in objective assessments of physical activity and musculoskeletal imaging and the use of digital health tools to support healthy and independent aging.

    Jakub Mesinovic, PhD

    Jakub Mesinovic, PhD

    Research Fellow

    Deakin University

    Dr. Jakub Mesinovic is a research fellow at the Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences at Deakin University. His research focuses on improving metabolic and musculoskeletal health in older adults with obesity.

    He has led and contributed to clinical trials and meta-analyses examining the effects of exercise, energy restriction, and vitamin D supplementation on body composition, physical function, and bone health. He has a particular interest in musculoskeletal imaging - including DXA and HR-pQCT - and strategies to optimize weight loss while preserving muscle and bone mass in later life.

  • Product Image: Gene Editing in Cells and Mice

    Gene Editing in Cells and Mice
    Contains 1 Component(s) Recorded On: 05/22/2026

    ASBMR 2018 Webinar: Gene Editing in Cells and Mice

    ASBMR 2018 Webinar: Gene Editing in Cells and Mice

  • Product Image: When Can We Stop Osteoporosis Treatment?

    When Can We Stop Osteoporosis Treatment?
    Contains 1 Component(s) Recorded On: 04/30/2026

    On Tuesday, April 13, 2021 from 1:00 pm EST - 2:00 pm EST, Dr. Richard Eastell, MD, FRCP, FRCPath, FMedSci and Dr. Lorenza Mattia of the University of Sheffield, UK present on the topic "When can we stop osteoporosis treatment?"

    Dr. Richard Eastell, MD, FRCP, FRCPath, FMedSci and Dr. Lorenza Mattia of the University of Sheffield, UK present on the topic "When can we stop osteoporosis treatment?"

  • Product Image: Women's History Month Virtual Panel Discussion on Topics in Mentoring

    Women's History Month Virtual Panel Discussion on Topics in Mentoring
    Contains 1 Component(s)

    ASBMR President Peter Ebeling and President-Elect Mary Bouxsein, "How Mentoring Impacted My Career Path"; Jillian Cornish, Ph.D., "How to be a Successful Mentor" Nancy Lane, M.D., "Mentoring in Academia = Ways Your Institute or Society Can Support You", Sherri-Ann Burnett-Bowie, M.D., M.P.H, "Tips for Mentees in the Clinical Environment"

    ASBMR President Peter Ebeling and President-Elect Mary Bouxsein, "How Mentoring Impacted My Career Path"; Jillian Cornish, Ph.D., "How to be a Successful Mentor" Nancy Lane, M.D., "Mentoring in Academia = Ways Your Institute or Society Can Support You", Sherri-Ann Burnett-Bowie, M.D., M.P.H, "Tips for Mentees in the Clinical Environment"